#USA #New York #Class Action #Securities Fraud #Hims & Hers Health

Recent Class Action Against Hims & Hers Health, Inc.

On August 19, 2025, Levi & Korsinsky, LLP announced a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS), aiming to assist investors who may have suffered losses due to alleged fraudulent activities. This lawsuit is crucial for stakeholders concerned about the integrity of the company's business practices and its impact on their investments.

Background of the Lawsuit

The class action seeks to address grievances from investors who were affected by purported securities fraud that transpired between April 29, 2025, and June 23, 2025. According to the filed complaint, several significant allegations were made against Hims that raise serious concerns:

1. Deceptive Practices: The company was accused of engaging in misleading practices by promoting and selling illegitimate versions of the medication Wegovy, which jeopardized patient safety.
2. Risk of Collaboration Termination: The allegations suggest a potential risk to Hims's collaboration with Novo Nordisk, a major pharmaceutical company. The concerns raised by the fraudulent activities could jeopardize this critical partnership.
3. Misleading Statements: The lawsuit claims that the company's leadership made overly positive statements regarding its business operations and prospects, which were misleading or lacked a factual basis.

Key Dates for Investors

Investors who believe they have been affected by these developments have a critical deadline approaching. Those who suffered a financial loss during the specified timeframe need to act quickly, as the deadline to request lead plaintiff status is August 25, 2025. It is important to note that participating in the class action does not require serving as a lead plaintiff, allowing more investors to seek recovery for their losses.

No Financial Burden for Participants

One of the most compelling aspects of joining this class action is that there are no out-of-pocket costs for class members. Levi & Korsinsky assures that individuals can pursue compensation without any financial obligation. This removes a significant barrier for investors who might have hesitated due to concerns over potential legal costs.

Expertise Behind the Case

Levi & Korsinsky has established a strong reputation over the past two decades, recovering hundreds of millions of dollars for shareholders and successfully handling high-stakes securities litigation. Their proficiency in navigating complex legal matters related to securities makes them a trusted partner for affected investors. Notably, the firm has ranked in the top tier of securities litigation firms for several consecutive years, as recognized by ISS Securities Class Action Services.

How to Get Involved

Investors interested in the class action can directly contact Levi & Korsinsky for further information. Joseph E. Levi, Esq. is leading the charge and can be reached via email at [email protected], or by phone at (212) 363-7500. Those who wish to join the class action should complete the submission form linked in the announcement.

Conclusion

This class action represents an important step towards accountability for Hims & Hers Health, Inc. Investors who have been affected now have an opportunity to seek justice and possibly recover their losses. It is advisable for stakeholders to stay informed about the case's progression and to utilize the resources available through Levi & Korsinsky.

In summary, the situation surrounding Hims & Hers Health serves as a critical reminder of the necessity for transparency and honesty in corporate governance, particularly within sectors where public health and safety are at stake.